• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Neuroimaging in Central Nervous System Lymphoma
Publication date: August 2016 Source:Hematology/Oncology Clinics of North America, Volume 30, Issue 4 Author(s): Seyed Ali Nabavizadeh, Arastoo Vossough, Mehrdad Hajmomenian, Reza Assadsangabi, Suyash MohanTeaser Primary central nervous system lymphoma (PCNSL) is a rare aggressive high-grade type of extranodal lymphoma. PCNSL can have a variable imaging appearance and can mimic other brain disorders such as encephalitis, demyelination, and stroke. In addition to PCNSL, the CNS can be secondarily involved by systemic lymphoma. Computed tomography and conventional MRI are the initial imaging modalities to evaluate the...
Source: Hematology Oncology Clinics of North America - July 19, 2016 Category: Hematology Source Type: research

Imaging Manifestations of Neurologic Complications in Anemia
Publication date: Available online 7 June 2016 Source:Hematology/Oncology Clinics of North America Author(s): Ritesh Patel, Shyam Sabat, Sangam KanekarTeaser The hallmark signs and symptoms of anemia are directly related to a decrease in oxygen delivery to vital tissues and organs and include pallor, fatigue, lightheadedness, and shortness of breath. Neurologic complications are often nonspecific and can include poor concentration, irritability, faintness, tinnitus, and headache. If undiagnosed or untreated, anemia can progress to cognitive dysfunction, psychosis, encephalopathy, myelopathy, peripheral neuropathy, and...
Source: Hematology Oncology Clinics of North America - June 6, 2016 Category: Hematology Source Type: research

Management of Patients with Sickle Cell Disease Using Transfusion Therapy
Publication date: June 2016 Source:Hematology/Oncology Clinics of North America, Volume 30, Issue 3 Author(s): Stella T. Chou, Ross M. FasanoTeaser Red blood cell (RBC) transfusion therapy is a key component of comprehensive management of patients with sickle cell disease (SCD) and has increased over time as a means of primary and secondary stroke prevention. RBC transfusions also prove to be lifesaving for many acute sickle cell–related complications. Although episodic and chronic transfusion therapy has significantly improved the morbidity and mortality of patients with SCD, transfusions are not without adverse eff...
Source: Hematology Oncology Clinics of North America - April 23, 2016 Category: Hematology Source Type: research